APA (7th ed.) Citation

P, K., M, M., SP, S., BP, P., V, K., G, B., . . . BS, P. (2022). Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection. Virology, 572, 64. https://doi.org/10.1016/j.virol.2022.05.004

Chicago Style (17th ed.) Citation

P, Kumar, Mathayan M, Smieszek SP, Przychodzen BP, Koprivica V, Birznieks G, Polymeropoulos MH, and Prabhakar BS. "Identification of Potential COVID-19 Treatment Compounds Which Inhibit SARS Cov2 Prototypic, Delta and Omicron Variant Infection." Virology 572 (2022): 64. https://doi.org/10.1016/j.virol.2022.05.004.

MLA (9th ed.) Citation

P, Kumar, et al. "Identification of Potential COVID-19 Treatment Compounds Which Inhibit SARS Cov2 Prototypic, Delta and Omicron Variant Infection." Virology, vol. 572, 2022, p. 64, https://doi.org/10.1016/j.virol.2022.05.004.